# Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/PCSA/processa-pharmaceuticals-to-attend-44th-annual-j-p-morgan-healthcare-conference
Ticker: PCSA
Company: Processa Pharmaceuticals
Source: Processa Pharmaceuticals
Published: 2026-01-12 14:15 EST
Original Source URL: https://www.processapharmaceuticals.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-29 11:30 EST — [PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS](https://biopharmsignal.com/news/PCSA/processa-pharmaceuticals-inc-announces-acquisition-of-vidya-therapeutics-inc-and-589446e2) — Source: Processa Pharmaceuticals
- 2026-01-12 14:15 EST — [Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference](https://biopharmsignal.com/news/PCSA/processa-pharmaceuticals-to-attend-44th-annual-j-p-morgan-healthcare-conference) — Source: Processa Pharmaceuticals
- 2026-01-05 14:15 EST — [Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study](https://biopharmsignal.com/news/PCSA/processa-pharmaceuticals-completes-enrollment-of-20th-patient-for-formal-interim-analysis-in-phase-2-ngc-cap-breast-cancer-study) — Source: Processa Pharmaceuticals
- 2025-12-17 13:00 EST — [Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer](https://biopharmsignal.com/news/PCSA/processa-pharmaceuticals-provides-clinical-update-on-phase-2-study-in-metastatic-breast-cancer) — Source: Processa Pharmaceuticals
- 2025-11-05 14:15 EST — [Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025](https://biopharmsignal.com/news/PCSA/processa-pharmaceuticals-announces-poster-presentation-of-adaptive-phase-2-3-pcs499-study-in-fsgs-at-asn-kidney-week-2025) — Source: Processa Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)